ArticleNucleic acids research2020

Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice.

Ji-Su Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.